GelrinC

DEVICE3 trials

Sponsors

Regentis Biomaterials, Regentis Biomaterials Ltd

Conditions

Articular Cartilage Defects in the Knee JointCartilage Lesion to the Femoral Condylecartilage defect cartilage lesion

Phase 1

Study to Evaluate the Safety and Performance of Treatment of Articular Cartilage Lesions Located on the Femoral Condyle With gelrinC

Regentis BiomaterialsCartilage Lesion to the Femoral Condyle

Start: 2009-09-30End: 2019-03-31Updated: 2017-10-09

Unknown Phase

Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects

Regentis BiomaterialsArticular Cartilage Defects in the Knee Joint

Start: 2017-11-14End: 2024-11-30Target: 181Updated: 2022-03-22

Study Protocol Title: A Prospective, Open-Label, Multicenter Pivotal Study to Evaluate the Safety and Efficacy of GelrinC® for the Treatment of Symptomatic Articular Cartilage Defects of the Femoral Condyle: A Comparison to Historical Control Microfracture

Active, not recruitingNL-OMON47786

Regentis Biomaterials Ltdcartilage defect cartilage lesion

Start: 2018-07-19Target: 10Updated: 2024-02-28